Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Hebei Yichen Industrial IPO (Part 1): Is It as Good as It Sounds?

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

Hebei Yichen Industrial / Equity Capital Markets

<p>We have covered the basics of the IPO in our earlier insight, <a href="https://www.smartkarma.com/insights/hebei-yichen-industrial-ipo-part-1-is-it-as-good-as-it-sounds" target="_blank">Hebei Yichen Industrial IPO (Part 1): Is It as Good as It Sounds?</a>, where we have touched on the company's business and concerns regarding its market position. In this insight, we will discuss the industry prospects, financials, and valuation, in addition, to running the deal through our framework. </p><h2>Our Thoughts (Continued from Part 1)</h2><h2>Industry - railway investment to plateau, HSR construction to slow</h2><ul><li>China's spending on the railway has…</li></ul>

We have covered the basics of the IPO in our earlier insight, Hebei Yichen Industrial IPO (Part 1): Is It as Good as It Sounds?, where we have touched on the company's business and concerns regarding its market position. In this insight, we will discuss the industry prospects, financials, and valuation, in addition, to running the deal through our framework. Our Thoughts (Continued from Part 1)Industry - railway investment to plateau, HSR construction to slowChina's spending on the railway has…

CRCC High Tech Equipment Corp Ltd (H) (1786 HK)

Hebei Yichen Industrial IPO (Part 2): Past Its Good Old Days; Banker Matters